← Open Payments lookup

CAITLYN O'BRIEN: Open Payments

NPI 1962100446 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,251 in 127 payments from 10 companies in 2025. Trend: 2023 $1,835 · 2024 $3,126 · 2025 $2,251

Food & beverage: $2,210Education: $41
CompanyPaymentsAmount
GlaxoSmithKline, LLC.27$468
Regeneron Healthcare Solutions, Inc.24$466
AstraZeneca Pharmaceuticals LP14$343
Novartis Pharmaceuticals Corporation17$245
GENZYME CORPORATION17$229
Amgen Inc.12$213
Takeda Pharmaceuticals U.S.A., Inc.12$196
BioCryst US Sales Co., LLC2$50
ARS Pharmaceuticals Operations, Inc.1$24
CSL Behring1$17

Products named: DUPIXENT, NUCALA, TEZSPIRE, CUVITRU, Rhapsido, AIRSUPRA, TRELEGY ELLIPTA, ORLADEYO.

Industry payments across MA — which companies pay providers there.